The global bioprocessing analytics equipment market is on the threshold of transformative growth, with recent projections anticipating a revenue increase from USD 485.1 million in 2022 to USD 633.6 ...
We think Silgan has a sound capital structure, and we think its consistent free cash flow generation will support its debt-service requirements and future capital-allocation decisions. Silgan has ...
The latest episode “Made in the USA” podcast explores a company that uses collaborative robots, one of the key tools helping US machine shops and other manufacturers compete with lower cost countries ...